Trial intelligence / Profile preview

Memantine for Alcohol Dependence

NCT00246415Phase 2Completed

Sponsor
National Institute on Alcohol Abuse and Alcoholism
Start
Nov 2002
Primary completion
Dec 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in alcohol dependence comparing Memantine with Placebo (2 arms). Primary endpoints: Alcohol consumption - Standard Drink Units at 3 months and Abstinence from alcohol at 3 months. Started Nov 2002; status: completed.

02

Drugs

memantine
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT00246415.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00246415.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call